文献速递腹部CT

一项多中心研究:基于CT影像组学列线图预测结直肠癌KRAS突变及预后

A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram.
PubMed 文献 · Abdom Radiol (NY) · 2024-02-23

回顾性纳入408例确诊结直肠癌患者,训练集168例、内部验证集111例、外部验证集129例,从原发肿瘤提取影像组学特征并与年龄、肿瘤位置整合构建列线图。列线图在训练集、内部验证集、外部验证集的AUC分别为0.834、0.813、0.811,可将患者分为高风险(KRAS突变)与低风险(KRAS野生型)组,两组总生存差异有统计学意义(P < 0.001),高风险组总生存较差。

要点

  • 基于原发肿瘤CT影像组学特征联合年龄、肿瘤位置构建的列线图可术前预测KRAS突变,外部验证AUC为0.811。
  • 列线图将患者分为高风险(KRAS突变)与低风险(KRAS野生型)组,两组总生存差异有统计学意义(P < 0.001),高风险组总生存较差。
  • 影像组学模型由19个与KRAS突变显著相关的特征构成,用于术前无创评估KRAS状态并分层预后。

核心结论

  • 基于CT的影像组学列线图可在术前有效预测结直肠癌患者KRAS突变并分层预后。

研究设计与样本

  • 回顾性分析纳入408例确诊结直肠癌患者,训练集168例、内部验证集111例、外部验证集129例;从原发肿瘤提取影像组学特征,结合临床显著参数构建列线图,以AUC评估诊断性能,用Kaplan-Meier分析高风险与低风险组生存曲线。

诊断标准与关键数值

  • 影像组学模型使用19个与KRAS突变显著相关的影像组学特征;列线图整合影像组学特征与两个临床显著参数(年龄、肿瘤位置)。

临床应用与阅片要点

  • 列线图在训练集、内部验证集、外部验证集的AUC分别为0.834、0.813、0.811;高风险(KRAS突变)组与低风险(KRAS野生型)组总生存差异有统计学意义(P < 0.001),高风险组总生存较低风险组差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To establish a CT-based radiomics nomogram for preoperative prediction of KRAS mutation and prognostic stratification in colorectal cancer (CRC) patients.

METHODS: In a retrospective analysis, 408 patients with confirmed CRC were included, comprising 168 cases in the training set, 111 cases in the internal validation set, and 129 cases in the external validation set. Radiomics features extracted from the primary tumors were meticulously screened to identify those closely associated with KRAS mutation. Subsequently, a radiomics nomogram was constructed by integrating these radiomics features with clinically significant parameters. The diagnostic performance was assessed through the area under the receiver operating characteristic curve (AUC). Lastly, the prognostic significance of the nomogram was explored, and Kaplan-Meier analysis was employed to depict survival curves for the high-risk and low-risk groups.

RESULTS: A radiomics model was constructed using 19 radiomics features significantly associated with KRAS mutation. Furthermore, a nomogram was developed by integrating these radiomics features with two clinically significant parameters (age, tumor location). The nomogram achieved AUCs of 0.834, 0.813, and 0.811 in the training set, internal validation set, and external validation set, respectively. Additionally, the nomogram effectively stratified patients into high-risk (KRAS mutation) and low-risk (KRAS wild-type) groups, demonstrating a significant difference in overall survival (P < 0.001). Patients categorized in the high-risk group exhibited inferior overall survival in contrast to those classified in the low-risk group.

CONCLUSIONS: The CT-based radiomics nomogram demonstrates the capability to effectively predict KRAS mutation in CRC patients and stratify their prognosis preoperatively.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Li M, Yuan Y, Zhou H, et al. A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram. Abdom Radiol (NY). 2024. PMID: 38393357. doi:10.1007/s00261-024-04218-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。